Cargando…
High Prevalence of PNH-phenotype Cells in Patients Who Received CD19-targeted CAR T-cell Therapy
| Autores principales: | , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Lippincott Williams & Wilkins
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8357245/ https://www.ncbi.nlm.nih.gov/pubmed/34396050 http://dx.doi.org/10.1097/HS9.0000000000000628 |
| _version_ | 1783737097947971584 |
|---|---|
| author | Yoshihara, Kyoko Matsuda, Ikuo Utsunomiya, Nobuto Samori, Mami Hirata, Saki Okada, Masaya Hirota, Seiichi Higasa, Satoshi Yoshihara, Satoshi |
| author_facet | Yoshihara, Kyoko Matsuda, Ikuo Utsunomiya, Nobuto Samori, Mami Hirata, Saki Okada, Masaya Hirota, Seiichi Higasa, Satoshi Yoshihara, Satoshi |
| author_sort | Yoshihara, Kyoko |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8357245 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | Lippincott Williams & Wilkins |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-83572452021-08-13 High Prevalence of PNH-phenotype Cells in Patients Who Received CD19-targeted CAR T-cell Therapy Yoshihara, Kyoko Matsuda, Ikuo Utsunomiya, Nobuto Samori, Mami Hirata, Saki Okada, Masaya Hirota, Seiichi Higasa, Satoshi Yoshihara, Satoshi Hemasphere Letter Lippincott Williams & Wilkins 2021-08-11 /pmc/articles/PMC8357245/ /pubmed/34396050 http://dx.doi.org/10.1097/HS9.0000000000000628 Text en Copyright © 2021 the Author(s). Published by Wolters Kluwer Health, Inc. on behalf of the European Hematology Association. https://creativecommons.org/licenses/by-nc-sa/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License (https://creativecommons.org/licenses/by-nc-sa/4.0/) , which allows others to remix, tweak, and build upon the work non-commercially, as long as the author is credited and the new creations are licensed under the identical terms. |
| spellingShingle | Letter Yoshihara, Kyoko Matsuda, Ikuo Utsunomiya, Nobuto Samori, Mami Hirata, Saki Okada, Masaya Hirota, Seiichi Higasa, Satoshi Yoshihara, Satoshi High Prevalence of PNH-phenotype Cells in Patients Who Received CD19-targeted CAR T-cell Therapy |
| title | High Prevalence of PNH-phenotype Cells in Patients Who Received CD19-targeted CAR T-cell Therapy |
| title_full | High Prevalence of PNH-phenotype Cells in Patients Who Received CD19-targeted CAR T-cell Therapy |
| title_fullStr | High Prevalence of PNH-phenotype Cells in Patients Who Received CD19-targeted CAR T-cell Therapy |
| title_full_unstemmed | High Prevalence of PNH-phenotype Cells in Patients Who Received CD19-targeted CAR T-cell Therapy |
| title_short | High Prevalence of PNH-phenotype Cells in Patients Who Received CD19-targeted CAR T-cell Therapy |
| title_sort | high prevalence of pnh-phenotype cells in patients who received cd19-targeted car t-cell therapy |
| topic | Letter |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8357245/ https://www.ncbi.nlm.nih.gov/pubmed/34396050 http://dx.doi.org/10.1097/HS9.0000000000000628 |
| work_keys_str_mv | AT yoshiharakyoko highprevalenceofpnhphenotypecellsinpatientswhoreceivedcd19targetedcartcelltherapy AT matsudaikuo highprevalenceofpnhphenotypecellsinpatientswhoreceivedcd19targetedcartcelltherapy AT utsunomiyanobuto highprevalenceofpnhphenotypecellsinpatientswhoreceivedcd19targetedcartcelltherapy AT samorimami highprevalenceofpnhphenotypecellsinpatientswhoreceivedcd19targetedcartcelltherapy AT hiratasaki highprevalenceofpnhphenotypecellsinpatientswhoreceivedcd19targetedcartcelltherapy AT okadamasaya highprevalenceofpnhphenotypecellsinpatientswhoreceivedcd19targetedcartcelltherapy AT hirotaseiichi highprevalenceofpnhphenotypecellsinpatientswhoreceivedcd19targetedcartcelltherapy AT higasasatoshi highprevalenceofpnhphenotypecellsinpatientswhoreceivedcd19targetedcartcelltherapy AT yoshiharasatoshi highprevalenceofpnhphenotypecellsinpatientswhoreceivedcd19targetedcartcelltherapy |